{"name":"D. Bradley Welling, MD, PhD","slug":"d-bradley-welling-md-phd","ticker":"","exchange":"","domain":"","description":"D. Bradley Welling, MD, PhD is a research-focused entity with expertise in the development of novel therapeutics. The company has a single discontinued drug candidate, Fibroblast Growth Factor 2, indicating a focus on early-stage research and development.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiaEFVX3lxTE1vRWRyT3FVakowNGREMlY5Znd6OXZOUlB1b3RBaW0zdjhYTUJLMnBBODB0b3BEaUhBRzhaWTJCWTdRcWRaN3lNXzNNYTJSOWlFN3lhSGp1ZS1DeWFBMmZGTXc1SUlJSzVw?oc=5","date":"2020-05-14","type":"pipeline","source":"Wiley Online Library","summary":"Topical fibroblast growth factor‐2 for treatment of chronic tympanic membrane perforations - Wiley Online Library","headline":"Topical fibroblast growth factor‐2 for treatment of chronic tympanic membrane perforations","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}